The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes

Samankaltaisia teoksia

• Nateglinide, but not repaglinide, stimulates growth hormone secretion from rat pituitary cells.
  Tekijä: Bokvist, K, et al.
  Julkaistu: (2000)
• Effect of nateglinide on the incidence of diabetes and cardiovascular events.
  Tekijä: Holman, R, et al.
  Julkaistu: (2010)
• A review of nateglinide in the management of patients with type 2 diabetes
  Tekijä: Nicholas Tentolouris, et al.
  Julkaistu: (2008-01-01)
• Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).
  Tekijä: Gribble, F, et al.
  Julkaistu: (2001)
• Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
  Tekijä: Califf, R, et al.
  Julkaistu: (2008)